SNP genotyping
Experts Urge FDA, CMS to Revoke Approval, Coverage for Opioid Addiction Genetic Risk Test
A coalition of experts in addiction, genetics, and public health wrote that an opioid addiction risk test from Solvd Health's AutoGenomics business performs no better than chance.
At the American College of Medical Genetics and Genomics annual meeting, members of two working groups provided an early look at new versions of the existing standards.
IVitalize Acquires Genetic Testing Laboratory Geneus Health
Geneus offers a genetic test to identify potential genetic predisposition to reward deficiency syndrome, a primary marker for addiction.
Investigators calculated that the new assay, which includes 67 SNPs, could offer a 50 percent improvement over previous methods if used in newborn screening.
The 72-SNP score is for men of European ancestry who don't have mutations in high penetrance risk genes or mutations in genes associated with aggressive disease.